="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

All sales are to be made pursuant to a previously signed/adopted 10b5-1 selling plan dated August 28, 2023 and all representations regarding non-public information were made as of the adoption of the plan.

Date of Notice

09/03/2024

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

08/28/2023

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

Peter Virsik

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

EPIX ESSA Pharma Inc

144: Remarks and Signature

ATTENTION:

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Latest EPIX Messages

Loading Messages....

ESSA Pharma Inc News

Loading Messages....

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

EPIX ESSA Pharma Inc

144: Remarks and Signature

ATTENTION:

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Latest EPIX Messages

Loading Messages....

ESSA Pharma Inc News

Loading Messages....

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free